{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:51:14Z","timestamp":1786989074747,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["BFU2013-47242-R"],"award-info":[{"award-number":["BFU2013-47242-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["BFU2016-77363-R"],"award-info":[{"award-number":["BFU2016-77363-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"EU 7th Framework Programme","doi-asserted-by":"publisher","award":["FP7-REGPOT-2012-CT2012-31637-IMBRAIN"],"award-info":[{"award-number":["FP7-REGPOT-2012-CT2012-31637-IMBRAIN"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"MICINN","doi-asserted-by":"publisher","award":["FPDI-2013-17981"],"award-info":[{"award-number":["FPDI-2013-17981"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007757","name":"ACIISI","doi-asserted-by":"publisher","award":["TESIS2015010082"],"award-info":[{"award-number":["TESIS2015010082"]}],"id":[{"id":"10.13039\/501100007757","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.expneurol.2017.10.019","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T13:17:10Z","timestamp":1508419030000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease"],"prefix":"10.1016","volume":"299","author":[{"given":"Diego","family":"Luis-Ravelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Est\u00e9vez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barroso-Chinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Afonso-Oramas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josmar","family":"Salas-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Rodr\u00edguez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Acevedo-Arozena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marcellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-7434","authenticated-orcid":false,"given":"Tom\u00e1s","family":"Gonz\u00e1lez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2017.10.019_bb0005","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/17425255.2011.614232","article-title":"Pharmacokinetic evaluation of pramipexole","volume":"7","author":"Antonini","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0010","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2165\/11585090-000000000-00000","article-title":"Role of pramipexole in the management of Parkinson's disease","volume":"23","author":"Antonini","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2007.04.043","article-title":"Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development","volume":"1156","author":"Araki","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington's disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease","volume":"42","author":"Augood","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0169-328X(94)90227-5","article-title":"Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies","volume":"23","author":"Bal","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0045","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nn.2153","article-title":"Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs","volume":"11","author":"Bateup","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(98)00307-4","article-title":"Pramipexole \u2014 a new dopamine agonist for the treatment of Parkinson's disease","volume":"163","author":"Bennett","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005128","article-title":"The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6\/2 transgenic mouse model of Huntington's disease","volume":"4","author":"Bett","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bj\u00f8rk\u00f8y","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0065","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4161\/cc.5.14.2929","article-title":"New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions","volume":"5","author":"Bodner","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","article-title":"The role of cell signalling in the crosstalk between autophagy and apoptosis","volume":"26","author":"Booth","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0080","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4161\/auto.20218","article-title":"Long time-lapse imaging reveals unique features of PARK2\/Parkin-mediated mitophagy in mature cortical neurons","volume":"8","author":"Cai","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington's disease","volume":"5","author":"Callahan","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1353-8020(00)00061-4","article-title":"Neuroprotective effects of D3 dopamine receptor agonists","volume":"7","author":"Carvey","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","article-title":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","volume":"74","author":"Castro-Hern\u00e1ndez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington's disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0105","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0766-3","article-title":"Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists","volume":"193","author":"Collins","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0120","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0130","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s40265-014-0322-5","article-title":"Pramipexole extended-release: a review of its use in patients with Parkinson's disease","volume":"74","author":"Frampton","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/mp.2011.105","article-title":"An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning","volume":"17","author":"French","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-7091-0932-8_18","article-title":"Integrating neurotransmission in striatal medium spiny neurons","volume":"970","author":"Girault","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0145","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.25159","article-title":"Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease","volume":"27","author":"Guo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","article-title":"The influence of huntingtin protein size on nuclear localization and cellular toxicity","volume":"141","author":"Hackam","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/310503a0","article-title":"DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1","volume":"310","author":"Hemmings","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0160","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A2018","article-title":"Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study","volume":"31","author":"Hobbs","year":"2010","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0165","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s12035-014-8932-1","article-title":"Polyglutamine aggregation in Huntington disease: does structure determine toxicity?","volume":"52","author":"Hoffner","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0170","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/jcbfm.2015.128","article-title":"De novo expression of dopamine D2 receptor on microglia after stroke","volume":"35","author":"Huck","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0175","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1471-4159.2005.03625.x","article-title":"Pramipexole protects against MPTP toxicity in non-human primates","volume":"96","author":"Iravani","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2006.11.004","article-title":"Dopamine D3 receptor agonists for protection and repair in Parkinson's disease","volume":"7","author":"Joyce","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0190","doi-asserted-by":"crossref","first-page":"27068","DOI":"10.1074\/jbc.M113.486076","article-title":"Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes","volume":"288","author":"Juenemann","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0195","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Katsuragi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nsmb.2787","article-title":"Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins","volume":"21","author":"Klionsky","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-008-1323-4","article-title":"The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats","volume":"203","author":"Koffarnus","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0215","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00429-012-0383-8","article-title":"Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model","volume":"217","author":"Li","year":"2012","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0225","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s11064-010-0214-3","article-title":"Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease","volume":"35","author":"Li","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0230","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2014.05.048","article-title":"Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family","volume":"158","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0235","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.devcel.2014.06.001","article-title":"Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway","volume":"30","author":"Maday","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0245","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1523\/JNEUROSCI.4401-15.2016","article-title":"Compartment-specific regulation of autophagy in primary neurons","volume":"36","author":"Maday","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0250","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201106120","article-title":"Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons","volume":"196","author":"Maday","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(97)00066-6","article-title":"The behavioural effects of pramipexole, a novel dopamine receptor agonist","volume":"324","author":"Maj","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0260","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0265","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Mari\u00f1o","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0275","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14656566.2016.1109630","article-title":"Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature","volume":"17","author":"Mason","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0893-133X(95)00150-C","article-title":"Dopamine receptor mRNA expression in human striatum and neocortex","volume":"15","author":"Meador-Woodruff","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0290","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/0197-0186(92)90208-9","article-title":"Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain","volume":"20","author":"Mengod","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0295","doi-asserted-by":"crossref","first-page":"15.16.1","DOI":"10.1002\/0471143030.cb1516s54","article-title":"Measurement of autophagic activity in mammalian cells","volume":"54","author":"Menzies","year":"2012","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2003.12.020","article-title":"Proteasome degrades soluble expanded polyglutamine completely and efficiently","volume":"16","author":"Michalik","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0305","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1523\/JNEUROSCI.0146-10.2010","article-title":"Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington's disease molecular pathogenesis","volume":"30","author":"Miller","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0310","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1074\/jbc.M806269200","article-title":"Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in Huntington disease","volume":"284","author":"Mitra","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0315","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.febslet.2015.05.041","article-title":"Prefibrillar huntingtin oligomers isolated from HD brain potently seed amyloid formation","volume":"589","author":"Morozova","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1471-4159.2004.02692.x","article-title":"Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions","volume":"91","author":"Nagaoka","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0330","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1523\/JNEUROSCI.17-21-08147.1997","article-title":"Bidirectional regulation of DARPP-32 phosphorylation by dopamine","volume":"17","author":"Nishi","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington's disease","volume":"7","author":"Ortega","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0340","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","article-title":"Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation","volume":"30","author":"Ortega","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0350","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0355","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0360","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuropharm.2014.07.021","article-title":"Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease","volume":"89","author":"Pietropaolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington's disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0375","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","article-title":"Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease","volume":"19","author":"Rose","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0385","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients","volume":"42","author":"Sapp","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0390","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1042\/BST20130134","article-title":"Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application ofautophagy enhancers","volume":"41","author":"Sarkar","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0395","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2004.06.029","article-title":"Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation","volume":"15","author":"Schaffar","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-1331.2012.03822.x","article-title":"Success rate, efficacy, and safety\/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease","volume":"20","author":"Schapira","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0405","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(13)70117-0","article-title":"Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial","volume":"12","author":"Schapira","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0410","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0415","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioural abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0425","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(24)39024-X","article-title":"Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and non-dopaminergic cell bodies and terminals","volume":"295","author":"Stanwood","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0430","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0435","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","article-title":"Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic","volume":"17","author":"Takahashi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0440","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0445","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","article-title":"LC3 conjugation system in mammalian autophagy","volume":"36","author":"Tanida","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0450","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005072-197404000-00008","article-title":"Studies on brain biopsies of patients with Huntington's chorea","volume":"33","author":"Tellez-Nagel","year":"1974","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0455","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"Van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0460","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0465","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1073\/pnas.1206362109","article-title":"Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0470","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1080\/15548627.2015.1100930","article-title":"A pivotal role of FOS-mediated BECN1\/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation","volume":"11","author":"Wang","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0480","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","article-title":"The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation","volume":"34","author":"Wong","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0485","series-title":"Animal Models of Drug Addiction","first-page":"240","article-title":"Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist","volume":"vol. 13","author":"Xi","year":"2007"},{"key":"10.1016\/j.expneurol.2017.10.019_bb0490","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fncel.2013.00012","article-title":"Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice","volume":"7","author":"Yamamura","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0495","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0500","doi-asserted-by":"crossref","first-page":"E7803","DOI":"10.1073\/pnas.1710549114","article-title":"Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2017.10.019_bb0505","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.parkreldis.2014.12.013","article-title":"Update on Huntington's disease: advances in care and emerging therapeutic options","volume":"21","author":"Zielonka","year":"2015","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617302790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488617302790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:41:31Z","timestamp":1750938091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488617302790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":101,"alternative-id":["S0014488617302790"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.019","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}